Literature DB >> 9027651

Double cancer of the stomach, one AFP-producing tumor.

T Hyodo1, R Kawamoto.   

Abstract

In recent years, many cases of alpha-fetoprotein-producing gastric cancer (AFPGC) characterized by increased serum levels of alpha-fetoprotein (AFP) and AFP positivity of the gastric cancer have been reported. Here we present a case of AFPGC coexistent with a different histological type of gastric cancer: The AFPGC was Borrmann type 1 advanced gastric cancer with multiple liver metastasis and appeared to produce both AFP and des-gamma-carboxy prothrombin (PIVKA-II). The second cancer was IIc type early gastric cancer and did not produce AFP. Despite receiving palliative chemotherapy, the patient died, due to hepatic failure, 45 days after admission.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9027651     DOI： 10.1007/bf02358614

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  15 in total

1.  Demonstration of a new protein fraction in serum from the human fetus.

Authors:  C G BERGSTRAND; B CZAR
Journal:  Scand J Clin Lab Invest       Date:  1956       Impact factor: 1.713

2.  Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.

Authors:  K Uefuji; T Ichikura; S Tamakuma
Journal:  Jpn J Clin Oncol       Date:  1994-06       Impact factor: 3.019

3.  Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.

Authors:  T Ishiguro; I Sugitachi; H Sakaguchi; S Itani
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

4.  [Existence of alpha feto protein during gastric-origin secondary cancer of the liver].

Authors:  J Bourreille; P Metayer; F Sauger; F Matray; A Fondimare
Journal:  Presse Med       Date:  1970-06-06       Impact factor: 1.228

5.  Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?

Authors:  A Ooi; I Nakanishi; N Sakamoto; Y Tsukada; Y Takahashi; T Minamoto; M Mai
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

6.  Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.

Authors:  H Matsunou; F Konishi; R E Jalal; N Yamamichi; A Mukawa
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

7.  Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.

Authors:  M Kudo; Y Takamine; K Nakamura; H Shirane; H Uchida; S Kasakura; T Kajiwara; Y Ibuki; M Hirasa; S Tomita
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

8.  The potential for the development of liver metastasis from alpha-fetoprotein-producing human gastric carcinomas in nude mice.

Authors:  H Sawada; K Nakatani; A Watanabe; T Nishiwada; T Okumura; Y Yamada; T Yano; Y Shino; T Yamada; M Tanase
Journal:  Jpn J Clin Oncol       Date:  1992-10       Impact factor: 3.019

9.  Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.

Authors:  Y C Chang; N Nagasue; S Abe; H Taniura; D D Kumar; T Nakamura
Journal:  Am J Gastroenterol       Date:  1992-03       Impact factor: 10.864

Review 10.  Hepatoid carcinoma of the stomach.

Authors:  A deLorimier; F Park; G V Aranha; C Reyes
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860
View more
  3 in total

Review 1.  Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.

Authors:  Hao Xing; Cunling Yan; Liming Cheng; Nianyue Wang; Shuyang Dai; Jianyong Yuan; Wenfeng Lu; Zhouchong Wang; Jun Han; Yijie Zheng; Tian Yang
Journal:  Tumour Biol       Date:  2016-10-13

2.  Protein induced by vitamin K absence or antagonist II-producing gastric cancer.

Authors:  Yoshihisa Takahashi; Tohru Inoue; Toshio Fukusato
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

3.  Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).

Authors:  Kazuhiro Matsueda; Hiroshi Yamamoto; Yasuo Yoshida; Kenji Notohara
Journal:  J Gastroenterol       Date:  2006-11-09       Impact factor: 6.772
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.